Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics
Biff F Palmer,1 Amy D Rock,2 Emily J Woodward2 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 2Department of Research and Development, Cumberland Pharmaceuticals Inc., Nashville, TN, USA Purpose: This study aimed to evaluate the efficacy, safety...
Main Authors: | Palmer BF, Rock AD, Woodward EJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/dose-comparison-of-conivaptan-vaprisolreg-in-patients-with-euvolemic-o-peer-reviewed-article-DDDT |
Similar Items
-
Hyponatremia: A practical approach
by: Manisha Sahay, et al.
Published: (2014-01-01) -
Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01) -
Treating double-digit hyponatremia: walking a tight rope
by: Manjunath Kulkarni, et al.
Published: (2015-01-01) -
Effects of Hyponatremia on the Brain
by: Corinna Giuliani, et al.
Published: (2014-10-01) -
Sequential MRI in pontine and extrapontine myelinolysis following rapid correction of hyponatremia
by: Robert Laureno, et al.
Published: (2018-10-01)